Stay updated on TEPEZZA in Diffuse Sclerosis Clinical Trial
Sign up to get notified when there's something new on the TEPEZZA in Diffuse Sclerosis Clinical Trial page.

Latest updates to the TEPEZZA in Diffuse Sclerosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study record for TEPEZZA in diffuse cutaneous systemic sclerosis is populated with trial details, participant criteria, locations, and outcome measures. It also includes results and record dates, data-sharing information, and study documents.SummaryDifference51%

- Check16 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide notice announces NIH’s transition terminology update, including the use of “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check30 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now renders a 403 Forbidden error page, replacing the previous content and navigation with a standard access-denied layout. This indicates the study information is not accessible due to permission restrictions.SummaryDifference18%

Stay in the know with updates to TEPEZZA in Diffuse Sclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEPEZZA in Diffuse Sclerosis Clinical Trial page.